Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

DAR vs BIOX vs CF vs PGEN vs MOS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DAR
Darling Ingredients Inc.

Packaged Foods

Consumer DefensiveNYSE • US
Market Cap$10.02B
5Y Perf.+170.9%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$30M
5Y Perf.-93.0%
CF
CF Industries Holdings, Inc.

Agricultural Inputs

Basic MaterialsNYSE • US
Market Cap$17.67B
5Y Perf.+291.6%
PGEN
Precigen, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.23B
5Y Perf.+91.4%
MOS
The Mosaic Company

Agricultural Inputs

Basic MaterialsNYSE • US
Market Cap$7.04B
5Y Perf.+83.5%

DAR vs BIOX vs CF vs PGEN vs MOS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DAR logoDAR
BIOX logoBIOX
CF logoCF
PGEN logoPGEN
MOS logoMOS
IndustryPackaged FoodsAgricultural InputsAgricultural InputsBiotechnologyAgricultural Inputs
Market Cap$10.02B$30M$17.67B$1.23B$7.04B
Revenue (TTM)$6.14B$318M$7.41B$6M$11.68B
Net Income (TTM)$63M$-53M$1.76B$-247M$1.22B
Gross Margin15.7%39.1%40.4%23.0%16.5%
Operating Margin6.4%0.2%35.7%-18.6%9.9%
Forward P/E14.5x7.8x15.9x
Total Debt$4.16B$277M$3.95B$6M$760M
Cash & Equiv.$89M$33M$1.98B$30M$277M

DAR vs BIOX vs CF vs PGEN vs MOSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DAR
BIOX
CF
PGEN
MOS
StockMay 20May 26Return
Darling Ingredients… (DAR)100270.9+170.9%
Bioceres Crop Solut… (BIOX)1007.0-93.0%
CF Industries Holdi… (CF)100391.6+291.6%
Precigen, Inc. (PGEN)100191.4+91.4%
The Mosaic Company (MOS)100183.5+83.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: DAR vs BIOX vs CF vs PGEN vs MOS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CF leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. The Mosaic Company is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. PGEN also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
DAR
Darling Ingredients Inc.
The Long-Run Compounder

DAR is the clearest fit if your priority is long-term compounding.

  • 345.6% 10Y total return vs CF's 325.8%
Best for: long-term compounding
BIOX
Bioceres Crop Solutions Corp.
The Basic Materials Pick

Among these 5 stocks, BIOX doesn't own a clear edge in any measured category.

Best for: basic materials exposure
CF
CF Industries Holdings, Inc.
The Growth Play

CF carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.

  • Rev growth 19.3%, EPS growth 33.1%, 3Y rev CAGR -14.1%
  • PEG 0.18 vs MOS's 0.92
  • 19.3% revenue growth vs PGEN's -36.9%
  • Lower P/E (7.8x vs 15.9x), PEG 0.18 vs 0.92
Best for: growth exposure and valuation efficiency
PGEN
Precigen, Inc.
The Momentum Pick

PGEN ranks third and is worth considering specifically for momentum.

  • +211.9% vs BIOX's -89.5%
Best for: momentum
MOS
The Mosaic Company
The Income Pick

MOS is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 1 yrs, beta 0.51, yield 4.3%
  • Lower volatility, beta 0.51, Low D/E 6.2%, current ratio 1.32x
  • Beta 0.51, yield 4.3%, current ratio 1.32x
  • Beta 0.51 vs BIOX's 1.89, lower leverage
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthCF logoCF19.3% revenue growth vs PGEN's -36.9%
ValueCF logoCFLower P/E (7.8x vs 15.9x), PEG 0.18 vs 0.92
Quality / MarginsCF logoCF23.7% margin vs PGEN's -39.1%
Stability / SafetyMOS logoMOSBeta 0.51 vs BIOX's 1.89, lower leverage
DividendsMOS logoMOS4.3% yield, 1-year raise streak, vs CF's 1.7%, (3 stocks pay no dividend)
Momentum (1Y)PGEN logoPGEN+211.9% vs BIOX's -89.5%
Efficiency (ROA)CF logoCF12.4% ROA vs PGEN's -144.1%, ROIC 18.7% vs -152.8%

DAR vs BIOX vs CF vs PGEN vs MOS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DARDarling Ingredients Inc.
FY 2025
Feed Ingredients
65.0%$4.0B
Food Ingredients
25.2%$1.5B
Fuel Ingredients
9.8%$601M
BIOXBioceres Crop Solutions Corp.

Segment breakdown not available.

CFCF Industries Holdings, Inc.
FY 2025
Ammonia
33.3%$2.2B
UAN
33.0%$2.2B
Urea
27.2%$1.8B
AN
6.4%$421M
PGENPrecigen, Inc.
FY 2024
Exemplar Segment
100.0%$4M
MOSThe Mosaic Company
FY 2024
Phosphates Segment
39.9%$4.5B
Mosaic Fertilizantes
39.0%$4.4B
Potash Segment
21.1%$2.4B

DAR vs BIOX vs CF vs PGEN vs MOS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCFLAGGINGDAR

Income & Cash Flow (Last 12 Months)

CF leads this category, winning 5 of 6 comparable metrics.

MOS is the larger business by revenue, generating $11.7B annually — 1851.7x PGEN's $6M. CF is the more profitable business, keeping 23.7% of every revenue dollar as net income compared to PGEN's -39.1%. On growth, PGEN holds the edge at +2.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDAR logoDARDarling Ingredien…BIOX logoBIOXBioceres Crop Sol…CF logoCFCF Industries Hol…PGEN logoPGENPrecigen, Inc.MOS logoMOSThe Mosaic Company
RevenueTrailing 12 months$6.1B$318M$7.4B$6M$11.7B
EBITDAEarnings before interest/tax$901M$21M$3.5B-$115M$2.2B
Net IncomeAfter-tax profit$63M-$53M$1.8B-$247M$1.2B
Free Cash FlowCash after capex$679M$37M$1.6B-$76M-$535M
Gross MarginGross profit ÷ Revenue+15.7%+39.1%+40.4%+23.0%+16.5%
Operating MarginEBIT ÷ Revenue+6.4%+0.2%+35.7%-18.6%+9.9%
Net MarginNet income ÷ Revenue+1.0%-16.6%+23.7%-39.1%+10.5%
FCF MarginFCF ÷ Revenue+11.1%+11.5%+21.9%-12.0%-4.6%
Rev. Growth (YoY)Latest quarter vs prior year+21.2%-16.4%+19.4%+2.1%-7.5%
EPS Growth (YoY)Latest quarter vs prior year-42.9%-37.3%+115.1%-11.7%+3.8%
CF leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BIOX leads this category, winning 3 of 7 comparable metrics.

At 5.7x trailing earnings, MOS trades at a 96% valuation discount to DAR's 161.9x P/E. Adjusting for growth (PEG ratio), CF offers better value at 0.29x vs MOS's 0.33x — a lower PEG means you pay less per unit of expected earnings growth.

MetricDAR logoDARDarling Ingredien…BIOX logoBIOXBioceres Crop Sol…CF logoCFCF Industries Hol…PGEN logoPGENPrecigen, Inc.MOS logoMOSThe Mosaic Company
Market CapShares × price$10.0B$30M$17.7B$1.2B$7.0B
Enterprise ValueMkt cap + debt − cash$14.1B$274M$19.6B$1.2B$7.5B
Trailing P/EPrice ÷ TTM EPS161.90x-0.57x12.82x-8.96x5.72x
Forward P/EPrice ÷ next-FY EPS est.14.51x7.79x15.89x
PEG RatioP/E ÷ EPS growth rate0.29x0.33x
EV / EBITDAEnterprise value multiple15.59x19.99x6.02x3.48x
Price / SalesMarket cap ÷ Revenue1.63x0.09x2.49x314.13x0.60x
Price / BookPrice ÷ Book value/share2.10x0.10x2.40x29.27x0.53x
Price / FCFMarket cap ÷ FCF14.76x0.85x9.80x
BIOX leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

CF leads this category, winning 6 of 9 comparable metrics.

CF delivers a 22.3% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-6 for PGEN. MOS carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to BIOX's 0.94x. On the Piotroski fundamental quality scale (0–9), CF scores 8/9 vs PGEN's 3/9, reflecting strong financial health.

MetricDAR logoDARDarling Ingredien…BIOX logoBIOXBioceres Crop Sol…CF logoCFCF Industries Hol…PGEN logoPGENPrecigen, Inc.MOS logoMOSThe Mosaic Company
ROE (TTM)Return on equity+1.3%-16.7%+22.3%-5.9%+10.0%
ROA (TTM)Return on assets+0.6%-6.7%+12.4%-144.1%+5.0%
ROICReturn on invested capital+3.4%-0.5%+18.7%-152.8%+6.1%
ROCEReturn on capital employed+4.3%-0.8%+18.3%-107.2%+5.9%
Piotroski ScoreFundamental quality 0–973837
Debt / EquityFinancial leverage0.87x0.94x0.51x0.14x0.06x
Net DebtTotal debt minus cash$4.1B$244M$2.0B-$24M$483M
Cash & Equiv.Liquid assets$89M$33M$2.0B$30M$277M
Total DebtShort + long-term debt$4.2B$277M$3.9B$6M$760M
Interest CoverageEBIT ÷ Interest expense1.76x-0.07x16.31x-273.83x8.81x
CF leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PGEN leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in CF five years ago would be worth $22,598 today (with dividends reinvested), compared to $313 for BIOX. Over the past 12 months, PGEN leads with a +211.9% total return vs BIOX's -89.5%. The 3-year compound annual growth rate (CAGR) favors PGEN at 49.9% vs BIOX's -64.0% — a key indicator of consistent wealth creation.

MetricDAR logoDARDarling Ingredien…BIOX logoBIOXBioceres Crop Sol…CF logoCFCF Industries Hol…PGEN logoPGENPrecigen, Inc.MOS logoMOSThe Mosaic Company
YTD ReturnYear-to-date+67.7%-65.2%+44.1%-1.6%-10.4%
1-Year ReturnPast 12 months+86.5%-89.5%+43.9%+211.9%-28.5%
3-Year ReturnCumulative with dividends+9.6%-95.3%+78.6%+236.8%-34.6%
5-Year ReturnCumulative with dividends-12.7%-96.9%+126.0%-32.5%-26.9%
10-Year ReturnCumulative with dividends+345.6%-95.1%+325.8%-84.4%+12.0%
CAGR (3Y)Annualised 3-year return+3.1%-64.0%+21.3%+49.9%-13.2%
PGEN leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DAR and CF each lead in 1 of 2 comparable metrics.

CF is the less volatile stock with a -0.69 beta — it tends to amplify market swings less than BIOX's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DAR currently trades 95.6% from its 52-week high vs BIOX's 9.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDAR logoDARDarling Ingredien…BIOX logoBIOXBioceres Crop Sol…CF logoCFCF Industries Hol…PGEN logoPGENPrecigen, Inc.MOS logoMOSThe Mosaic Company
Beta (5Y)Sensitivity to S&P 5000.71x1.89x-0.69x1.43x0.51x
52-Week HighHighest price in past year$66.02$5.18$141.96$5.23$38.23
52-Week LowLowest price in past year$29.15$0.35$75.42$1.23$22.18
% of 52W HighCurrent price vs 52-week peak+95.6%+9.1%+81.0%+80.5%+58.0%
RSI (14)Momentum oscillator 0–10054.743.546.053.438.1
Avg Volume (50D)Average daily shares traded2.8M799K4.9M4.2M9.5M
Evenly matched — DAR and CF each lead in 1 of 2 comparable metrics.

Analyst Outlook

MOS leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: DAR as "Buy", CF as "Buy", PGEN as "Buy", MOS as "Hold". Consensus price targets imply 42.5% upside for PGEN (target: $6) vs -5.3% for CF (target: $109). For income investors, MOS offers the higher dividend yield at 4.28% vs CF's 1.75%.

MetricDAR logoDARDarling Ingredien…BIOX logoBIOXBioceres Crop Sol…CF logoCFCF Industries Hol…PGEN logoPGENPrecigen, Inc.MOS logoMOSThe Mosaic Company
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$65.33$108.89$6.00$31.25
# AnalystsCovering analysts25411649
Dividend YieldAnnual dividend ÷ price+1.7%+4.3%
Dividend StreakConsecutive years of raises101
Dividend / ShareAnnual DPS$2.01$0.95
Buyback YieldShare repurchases ÷ mkt cap+0.3%+3.1%0.0%0.0%0.0%
MOS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CF leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BIOX leads in 1 (Valuation Metrics). 1 tied.

Best OverallCF Industries Holdings, Inc. (CF)Leads 2 of 6 categories
Loading custom metrics...

DAR vs BIOX vs CF vs PGEN vs MOS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is DAR or BIOX or CF or PGEN or MOS a better buy right now?

For growth investors, CF Industries Holdings, Inc.

(CF) is the stronger pick with 19. 3% revenue growth year-over-year, versus -36. 9% for Precigen, Inc. (PGEN). The Mosaic Company (MOS) offers the better valuation at 5. 7x trailing P/E (15. 9x forward), making it the more compelling value choice. Analysts rate Darling Ingredients Inc. (DAR) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DAR or BIOX or CF or PGEN or MOS?

On trailing P/E, The Mosaic Company (MOS) is the cheapest at 5.

7x versus Darling Ingredients Inc. at 161. 9x. On forward P/E, CF Industries Holdings, Inc. is actually cheaper at 7. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CF Industries Holdings, Inc. wins at 0. 18x versus The Mosaic Company's 0. 92x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — DAR or BIOX or CF or PGEN or MOS?

Over the past 5 years, CF Industries Holdings, Inc.

(CF) delivered a total return of +126. 0%, compared to -96. 9% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: DAR returned +345. 6% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DAR or BIOX or CF or PGEN or MOS?

By beta (market sensitivity over 5 years), CF Industries Holdings, Inc.

(CF) is the lower-risk stock at -0. 69β versus Bioceres Crop Solutions Corp. 's 1. 89β — meaning BIOX is approximately -373% more volatile than CF relative to the S&P 500. On balance sheet safety, The Mosaic Company (MOS) carries a lower debt/equity ratio of 6% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — DAR or BIOX or CF or PGEN or MOS?

By revenue growth (latest reported year), CF Industries Holdings, Inc.

(CF) is pulling ahead at 19. 3% versus -36. 9% for Precigen, Inc. (PGEN). On earnings-per-share growth, the picture is similar: The Mosaic Company grew EPS 605. 5% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DAR or BIOX or CF or PGEN or MOS?

CF Industries Holdings, Inc.

(CF) is the more profitable company, earning 20. 5% net margin versus -32. 2% for Precigen, Inc. — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CF leads at 33. 4% versus -34. 4% for PGEN. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DAR or BIOX or CF or PGEN or MOS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CF Industries Holdings, Inc. (CF) is the more undervalued stock at a PEG of 0. 18x versus The Mosaic Company's 0. 92x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CF Industries Holdings, Inc. (CF) trades at 7. 8x forward P/E versus 15. 9x for The Mosaic Company — 8. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PGEN: 42. 5% to $6. 00.

08

Which pays a better dividend — DAR or BIOX or CF or PGEN or MOS?

In this comparison, MOS (4.

3% yield), CF (1. 7% yield) pay a dividend. DAR, BIOX, PGEN do not pay a meaningful dividend and should not be held primarily for income.

09

Is DAR or BIOX or CF or PGEN or MOS better for a retirement portfolio?

For long-horizon retirement investors, CF Industries Holdings, Inc.

(CF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 69), 1. 7% yield, +325. 8% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CF: +325. 8%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DAR and BIOX and CF and PGEN and MOS?

These companies operate in different sectors (DAR (Consumer Defensive) and BIOX (Basic Materials) and CF (Basic Materials) and PGEN (Healthcare) and MOS (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DAR is a mid-cap quality compounder stock; BIOX is a small-cap quality compounder stock; CF is a mid-cap high-growth stock; PGEN is a small-cap quality compounder stock; MOS is a small-cap deep-value stock. CF, MOS pay a dividend while DAR, BIOX, PGEN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

DAR

High-Growth Disruptor

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 10%
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Stocks Like

CF

High-Growth Quality Leader

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 14%
Run This Screen
Stocks Like

PGEN

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 103%
  • Gross Margin > 13%
Run This Screen
Stocks Like

MOS

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 6%
  • Dividend Yield > 1.7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DAR and BIOX and CF and PGEN and MOS on the metrics below

Revenue Growth>
%
(DAR: 21.2% · BIOX: -16.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.